Jörg Hartkamp
Impact in
-
- PI3K/AKT/mTOR signaling in cancer
- Melanoma and MAPK Pathways
- Renal and related cancers
- Protein Kinase Regulation and GTPase Signaling
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
-
- PARP inhibition in cancer therapy
Papers in
-
- Renal and related cancers 4
- Cell death mechanisms and regulation 3
- Protein Kinase Regulation and GTPase Signaling 2
- Histone Deacetylase Inhibitors Research 2
- Melanoma and MAPK Pathways 2
- Oncology 6
- PARP inhibition in cancer therapy 3
- Co-authors
- Stefan G. E. Roberts (3 shared papers)Jakob Troppmair (3 shared papers)Ulf Rüdiger Rapp (2 shared papers)Brian Carpenter (1 shared paper)Oliver Holger Krämer (4 shared papers)Takahiro Nobukuni (1 shared paper)Julian R. Sampson (1 shared paper)George Thomas (1 shared paper)
- Journals
- Scientific Reports (2 papers)Journal of Neuroimmunology (1 paper)FEBS Journal (1 paper)The Journal of Cell Biology (1 paper)Leukemia (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Jörg Hartkamp
18 papers receiving 585 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 447
- Oncology 132
- Cancer Research 59
- Cell Biology 67
- Physiology 94
Countries citing papers authored by Jörg Hartkamp
This map shows the geographic impact of Jörg Hartkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hartkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hartkamp more than expected).
Fields of papers citing papers by Jörg Hartkamp
This network shows the impact of papers produced by Jörg Hartkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hartkamp. The network helps show where Jörg Hartkamp may publish in the future.
Co-authors
The 25 scholars most cited alongside Jörg Hartkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 173 | |
| 2 | 2010 | 66 | |
| 3 | The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. | 1999 | 57 |
| 4 | 2013 | 53 | |
| 5 | 2012 | 50 | |
| 6 | 1998 | 46 | |
| 7 | 2014 | 27 | |
| 8 | 2008 | 25 | |
| 9 | 2019 | 25 | |
| 10 | 2017 | 23 | |
| 11 | 2021 | 21 | |
| 12 | 2018 | 14 | |
| 13 | 2010 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2002 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2021 | 2 | |
| 18 | 2016 | 1 |
About Jörg Hartkamp
Jörg Hartkamp is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Physiology, having authored 18 papers that have together received 606 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Cell death mechanisms and regulation (3 papers), PARP inhibition in cancer therapy (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Renal cell carcinoma treatment (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Lysosomal Storage Disorders Research (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Molecular Biology (447 citations), Oncology (132 citations), Cancer Research (59 citations), Cell Biology (67 citations) and Physiology (94 citations). Jörg Hartkamp has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Stefan G. E. Roberts, Jakob Troppmair, Ulf Rüdiger Rapp, Brian Carpenter, Oliver Holger Krämer, Takahiro Nobukuni, Julian R. Sampson, George Thomas, Richard F. Lamb and Wendy Wassyng Roworth. Their work appears in journals such as Scientific Reports, Journal of Neuroimmunology, FEBS Journal, The Journal of Cell Biology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.